0002137361-26-000006.txt : 20261007 0002137361-26-000006.hdr.sgml : 20261007 20261007150715 ACCESSION NUMBER: 0002137361-26-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261007 DATE AS OF CHANGE: 20261007 EFFECTIVENESS DATE: 20261007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Monocacy Therapeutics Inc. CENTRAL INDEX KEY: 0002137361 ORGANIZATION NAME: EIN: 412998999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-600320 FILM NUMBER: 261446764 BUSINESS ADDRESS: STREET 1: 4716 MONROVIA BLVD CITY: MONROVIA STATE: MD ZIP: 21770 BUSINESS PHONE: 3019790911 MAIL ADDRESS: STREET 1: 4716 MONROVIA BLVD CITY: MONROVIA STATE: MD ZIP: 21770 D 1 primary_doc.xml X0708 D LIVE 0002137361 Monocacy Therapeutics Inc. 4716 MONROVIA BLVD MONROVIA MD MARYLAND 21770 3019790911 DELAWARE None None Corporation true 2025 Suman Vodnala 2835 Crusader Street Alameda CA CALIFORNIA 94501 Executive Officer Shashank Patel 4716 Monrovia Blvd Monrovia MD MARYLAND 21770 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-09-25 true true Simple Agreement for Future Equity (SAFE) false 0 25000 25000 0 false 1 0 0 0 false Monocacy Therapeutics Inc. /s/ Shashank Patel Shashank Patel President 2026-10-02